Dr Neil Love 공개
[search 0]

Download the App!

show episodes
 
Loading …
show series
 
Dr Sagar Lonial from the Winship Cancer Institute in Atlanta, Georgia, discuses key presentations on the management of multiple myeloma from the 2020 ASH Annual Meeting. CME information and select publications here저자 Research To Practice
 
Dr David Quinn from the University of Southern California in Los Angeles discusses the impact of COVID-19 on the management of cancer and the current challenges he is experiencing as a physician caring for patients at the front line of the pandemic. Additional resources Lee LYW et al. COVID-19 mortality in patients with cancer on chemotherapy or ot…
 
Dr Stephen Liu from Georgetown University Hospital in Washington, DC, discusses recently published and emerging research on the role of immunotherapy combination approaches in the treatment of metastatic non-small cell lung cancer. CME information and select publications here.저자 Research To Practice
 
Dr David O’Malley from the Ohio State University and The James Cancer Center in Columbus discusses the current and future roles of immune checkpoint inhibitors and other novel therapies in the management of gynecologic cancers. CME information and select publications here.저자 Research To Practice
 
Dr Philip A Philip from the Karmanos Cancer Institute in Detroit, Michigan, discusses recent data sets in gastrointestinal cancers from the ASCO and ESMO 2020 meetings that are most likely to have an impact on clinical practice. Faculty information and select publications here.저자 Research To Practice
 
Dr Eric Klein from the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio, discusses the role of liquid biopsy for cancer detection, including his experience with the Circulating Cell-Free Genome Atlas study. Faculty information and select publications here.저자 Research To Practice
 
Professor Stephen Johnston from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London discusses the role of CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer. CME information and select publications here.저자 Research To Practice
 
Dr Ross Camidge from the University of Colorado in Denver discusses recently published and emerging research in the management of non-small cell lung cancer with ALK and ROS1 rearrangements. CME information and select publications here.저자 Research To Practice
 
Dr Ashish Kamat from the University of Texas MD Anderson Cancer Center in Houston discusses recently published and emerging research on the use of immune checkpoint inhibitors and other novel therapies for patients with urothelial bladder cancer. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Keith Pratz from the University of Pennsylvania in Philadelphia to discuss recently published and emerging research in the use of FLT3 inhibitors for patients with acute myeloid leukemia. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Tanya Siddiqi from the City of Hope National Medical Center in Duarte, California, to discuss recently published and emerging research in the use of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma. CME information and select publications here.…
 
For this special edition of Oncology Today, I met with Dr Kim Reiss Binder from the Abramson Cancer Center in Philadelphia to discuss recently published and emerging research on the use of PARP inhibitors in pancreatic cancer. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Courtney DiNardo from the MD Anderson Cancer Center in Houston, Texas, to discuss recently published and emerging research on the management of acute myeloid leukemia not eligible for intensive induction therapy. CME information and select publications here.…
 
For this special edition of Oncology Today, I met with Dr John Pagel from the Swedish Cancer Institute in Seattle to discuss recently published and emerging research in the front-line treatment of chronic lymphocytic leukemia. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Jeffrey Lancet from the Moffitt Cancer Center in Tampa, Florida, to discuss recently published and emerging research on induction and maintenance strategies for patients with acute myeloid leukemia. CME information and select publications here.…
 
For this special edition of Oncology Today, I met with Dr Susan Domchek from the University of Pennsylvania in Philadelphia to discuss recently published and emerging research on the use of PARP inhibitors in breast cancer. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Srdan Verstovsek from the MD Anderson Cancer Center in Houston, Texas, to discuss recently published and emerging research in the management of myeloproliferative neoplasms. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts to discuss recently published and emerging research in the management of EGFR mutation-positive non-small cell lung cancer. CME information and select publications here.…
 
For this special edition of Oncology Today, I met with Dr Nikhil Munshi from the Dana-Farber Cancer Institute in Boston to discuss recently published and emerging research on the use of CAR T-cell therapy in multiple myeloma. CME information and select publications here.저자 Research To Practice
 
For this special edition of Oncology Today, I met with Dr Petros Grivas from the Fred Hutchinson Cancer Research Center in Seattle to discuss recently published and emerging research on the use of immunotherapy in the management of urothelial bladder carcinoma. CME information and select publications here.…
 
For this special edition of Oncology Today, I met with Dr Nikhil Khushalani from the Moffitt Cancer Center in Tampa, Florida, to discuss recently published and emerging research including the use of the immune checkpoint inhibitors cemiplimab and pembrolizumab in the management of cutaneous squamous cell carcinoma. CME information and select public…
 
For this special edition of Oncology Today, I met with Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York to discuss recently published and emerging research in the management of small cell lung cancer (SCLC), including the recent approval of lurbinectedin as second-line treatment for extensive-stage SCLC. CME information and …
 
For this special edition of Oncology Today, Dr Neil Love discusses recently published and emerging research in follicular lymphoma with Drs Carla Casulo from the University of Rochester Wilmot Cancer Center and John P Leonard from the Weill Medical College of Cornell. CME information and select publications here.…
 
Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic. RTP Lung Cancer Summit: https://www.researchtopractice.com/LungCancerSummit20/ Additional Resources Calabro L et al. Challenges in …
 
Is it worthwhile to treat pancreatic cancer? Dr Michael Pishvaian from Johns Hopkins University discusses the use of the PARP inhibitor olaparib and other new developments in the disease. Additional Resources Golan T et al. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med 2019;381:317-27. Full text Burris HA…
 
Dr Jeff Sharman from the Willamette Valley Cancer Institute and Research Center discusses clinical trials evaluating the use of Bruton tyrosine kinase inhibitors as treatment for patients with SARS-CoV-2. Additional Resources Roschewski M et al. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Science Immunol 2019;5(48):eabd01…
 
Oncology nurse practitioner Kelly Goodwin discusses current treatment practices at Massachusetts General Hospital, the challenges encountered treating patients with cancer during COVID-19, and the use of telemedicine in oncology care. Additional Resources Catlin N. Navigating the COVID-19 pandemic as an oncology nurse. Oncology Times 2020;42(8):1,1…
 
Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors. RTP Lung Cancer Summit Presentations Additional Resources Banna G et al. How we treat patients with lung cancer during the …
 
Dr Kathleen Moore from the Stephenson Cancer Cetner and co-chair of the SGO 2020 Annual Meeting discusses COVID guidelines and the impact of the pandemic on clinical research and the treatment of ovarian cancer. Akladios C et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN Group for …
 
Dr Julie Gralow, Director of Breast Medical Oncology at the Seattle Cancer Care Alliance, reviews how telemedicine and the screening, diagnosis and treatment of breast cancer have rapidly adapted based on resource limitations and risk factors related to COVID-19. Additional Resources Soran A et al. Breast cancer diagnosis, and follow-up during COVI…
 
Dr Leora Horn of Vanderbilt University Medical Center discusses outcomes for patients with lung cancer and COVID-19 as well as the human implications of social distancing. Additional Resources AACR Virtual Annual Meeting I: April 27-28, 2020. COVID-19 and Cancer. AACR 2020. Session Garassino, MC. TERAVOLT (Thoracic cancERs international coVid 19 cO…
 
Dr Harold Burstein discusses how breast cancer is currently being managed at the Dana-Farber Cancer Institute with the constraints of social distancing and other COVID-19 considerations. COVID-19-Related Resources in Breast Cancer Dietz JR et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19…
 
In this second episode of our new podcast series, Dr Tom Lynch, who began his position as director of the Fred Hutchinson Cancer Research Center as Seattle became the first epicenter of the COVID-19 pandemic in the United States, comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the …
 
On this inaugural episode of our new podcast series, we address the treatment of prostate cancer in the era of COVID-19. Featuring interviews with Drs Neeraj Agarwal, Emmanuel Antonarakis and A Oliver Sartor. Additional Resources National Comprehensive Cancer Network (NCCN®). Recommendations of the NCCN: Management of prostate cancer during the COV…
 
Loading …

빠른 참조 가이드

Google login Twitter login Classic login